Which drugs does patent 6,558,707 protect, and when does it expire?
Patent 6,558,707 protects INSPRA and is included in one NDA. There has been one Paragraph IV challenge on Inspra.
Protection for INSPRA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty patent family members in twenty-seven countries.